Radiotherapy in Prostate Cancer

摘要: Therapeutic management of prostate cancer has become complex, multidisciplinary and stage-specific. (Heidenereich et al., 2011) Based on PSA level, histopathological grading clinical staging, is classified as low-, intermediateand high risk for disease recurrence. The status often plays a major role in deciding further therapy. (Kirby & Madhavan, 2010) It usually impossible to state that one therapy superior another because the lack randomized controlled trials. However some recommendations can be made. 2011, Aus al. 2001) European Association Urology 2010, patients with low-risk (PSA ≤10 ng/ml, Gleason score 20ng/ml, 8-10 or ≥cT3a) Choe Liauw, 2010). Radiotherapy widely used curative treatment modality cancer. There diverse array radiotherapeutic strategies effectively treat both organconfined locally advanced disease, alone combination androgen-deprivation Furthermore, it also significant post-prostatectomy setting, adjuvant salvage radiotherapy. In recent decades, radiotherapy undergone technological advances aim optimize control outcomes while minimizing morbidity. (Choe Hayden